tirzepatide safer than semaglutide vs. for Weight Loss is tirzepatide safer than semaglutide

Sharing is caring

10.4103/2229-5178.142528 26 HathcockJ

For persistent nausea, temporary dose reduction or extending the time at a lower dose before escalation may be necessary

However, if the patient experiences any serious side effects, the dose of the drug should be reduced or discontinued

Participants reporting liver-related adverse events, which were mostly non-serious, were higher in the semaglutide 2.4 mg group (7.5%) than with placebo (1.5%)

As a Pennsylvania-based mobile IV therapy provider serving communities from Philadelphia to Pittsburgh, RevIVe Mobile IV Therapy meets and exceeds these standards, bringing hospital-grade care directly to your doorstep